Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B [Thoracic Oncology]

Conclusion
DAS is a novel serum metabolite with significant performance in prediagnostic NSCLC and has additive performance with pro-SFTPB.

Source: Journal of Clinical Oncology - November 18, 2015 Category: Cancer & Oncology Authors: Wikoff, Hanash, DeFelice, Miyamoto, Barnett, Zhao, Goodman, Feng, Gandara, Fiehn, Taguchi Tags: Diagnosis & Staging, Cancer Biomarkers, Lung Thoracic Oncology Source Type: research